Analysis of Common Issues Regarding Changes in
Registration Items of Special Cosmetics

doi:10.1009-0959.2025.120010

Abstract

Abstract:

The change of registration items for special cosmetics is an important part of cosmetics registration management， but there are many problems in the actual change process. These issues may affect product safety and quality controllability. This study focuses on the actual needs in the field of special cosmetics regulation， based on the Regulations on Supervision and Administration of Cosmetics and supporting regulations and normative documents， taking the registration items of special cosmetics and the involved changes， such as product name change， production site change or addition， as the starting point to explore common problems in depth and analyze them in conjunction with regulations. On this basis， systematically classify and summarize the common problems， and propose rational suggestions， so as to provide clear guidance for cosmetics enterprises to standardize their application， help improve the quality of application materials， and promote the standardization of management for the changes of registration items for special cosmetics.

Key words: , Special cosmetics； , Change of registration items； , Product name change； , Production site change or addition

CLC Number:

TQ658
R95

FENG Mengxin, WANG Junqiu, LI Tingting, ZHANG Fenglan, YU Zhenxi.

Analysis of Common Issues Regarding Changes in Registration Items of Special Cosmetics [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(12): 1358-1358-1363.

References

［1］中华人民共和国国务院.《化妆品监督管理条例》（中华人民共和国国务院令第727号）［EB/OL］.（2020-06-29）［2025-05-12］.https：//www.nmpa.gov.cn/xxgk/fgwj/flxzhfg/20200629190501801.html.

［2］国家市场监督管理总局.《化妆品注册备案管理办法》（国家市场监督管理总局令第35号）［EB/OL］.（2021-01-07）［2025-05-12］.https：//gkml.samr.gov.cn/nsjg/fgs/202101/t20210112_325127.html.

［3］国家药品监督管理局.国家药监局关于发布《化妆品注册备案资料管理规定》的公告（2021年第32号）［EB/OL］.（2021-03-04）［2025-05-12］.https：//www.nmpa.gov.cn/xxgk/fgwj/xzhgfxwj/20210304140747119.html.

［4］国家药品监督管理局.国家药监局关于发布实施《化妆品标签管理办法》的公告（2021年第77号）［EB/OL］.（2021-06-03）［2025-05-12］.https：//www.nmpa.gov.cn/xxgk/fgwj/xzhgfxwj/20210603171933181.html.

［5］国家药品监督管理局.国家药监局关于发布实施《化妆品注册和备案检验工作规范》的公告（2019年第72号）［EB/OL］.（2019-09-03）［2025-05-12］.https：//www.nmpa.gov.cn/xxgk/fgwj/xzhgfxwj/20190910153001302.html.

［6］国家药品监督管理局.国家药监局关于发布《已使用化妆品原料目录（2021年版）》的公告（2021年第62号）［EB/OL］.（2021-04-30）［2025-05-12］.https：//www.nmpa.gov.cn/xxgk/ggtg/hzhpggtg/jmhzhptg/20210430162 707173.html.

［7］高家敏，苏哲，余振喜，等.欧盟化妆品纳米原料法规管理现状及思考［J］.香料香精化妆品，2022，（5）：82-88.

［8］黄湘鹭，罗飞亚，邢书霞，等.二氧化钛及其纳米颗粒在食品、药品和化妆品领域安全风险研究进展［J］.中国药理学与毒理学杂志，2023，37（1）：63-73.

［9］原国家食品药品监督管理总局.国家食品药品监督管理总局关于发布化妆品安全技术规范（2015年版）的公告（2015年第268号）［EB/OL］.（2015-12-23）［2025-05-12］.https：//www.nmpa.gov.cn/hzhp/hzhpfgwj/hzhpgzwj/20151223120001986.html.

［10］高家敏，张凤兰，袁欢，等.新法规下特殊化妆品注册技术要点分析［J］.香料香精化妆品，2022，（4）：58-62，68.

［11］何淼，李娅萍，袁欢，等.化妆品标签管理有关问题探讨［J］. 香料香精化妆品，2023，（1）：1-12，30.

［12］国家药品监督管理局.国家药监局关于发布《化妆品功效宣称评价规范》的公告（2021年第50号）［EB/OL］.（2021-04-09）［2025-05-12］.https：//www.nmpa.gov.cn/xxgk/fgwj/xzhgfxwj/20210409160321110.html.

［13］国家药品监督管理局.化妆品生产经营常见问题解答（二）［EB/OL］.（2024-05-10）［2025-05-12］.https：//www.nmpa.gov.cn/xxgk/zhcjd/zhcjdhzhp/20240510164245137.html.

［14］原国家食品药品监督管理总局.总局关于发布防晒化妆品防晒效果标识管理要求的公告（2016年第107号）［EB/OL］. （2016-06-01）［2025-05-12］.https：//www.nmpa.gov.cn/hzhp/hzhpfgwj/hzhpgzwj/20160601173101166.html.

［15］何锞，夏继斌，张一鸣，等.日晒伤研究进展［J］.临床外科杂志，2024，32（12）：1236-1239.

［16］吴景，刘敏，邢书霞，等.2018—2019年染发类化妆品质量安全状况分析［J］. 香料香精化妆品，2021，（1）：65-68，72.

［17］高家敏，王茜，宋钰，等.化妆品理化和微生物检验报告技术审评要点分析［J］.香料香精化妆品，2021，（4）：81-87.

［18］王聪，王茜，张凤兰.特殊化妆品安全评估常见问题探析［J］.香料香精化妆品，2025，（1）：79-83.

［19］中国食品药品检定研究院.中检院关于发布《毒理学关注阈值（TTC）方法应用技术指南》等3项技术文件的通知［EB/OL］.（2024-04-30）［2025-05-12］.https：//www.nifdc.org.cn//nifdc/bshff/hzhpbzh/hzhpbzhtzgg/202404 301622051057215.html.

［20］周奕霏，罗飞亚，孙磊，等.浅析《交叉参照（Read-across）方法应用技术指南》［J］.香料香精化妆品，2025，（2）：15-22.

［21］国家药品监督管理局.国家药监局关于发布《化妆品安全评估技术导则（2021年版）》的公告（2021年第51号）［EB/OL］.（2021-04-08）［2025-05-12］.https：//www.nmpa.gov.cn/xxgk/ggtg/hzhpggtg/jmhzhptg/2021041916 3037171.html.

[1]	WANG Caixue, SUN Ting, LI Xuan, SHAN Bin, WEN Tianjiao, WANG Mingxia. Analysis of Development Status and Challenges of Drug Clinical Trial Tnstitution in Hebei Province [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 995-1000.
[2]	JIAO Jian, XU Liang, YANG Lingyan. The Construction of A “Dual-Practice” Training Model for Inter-Disciplinary TCM Management Talents in Hospitals under the Background of "New Medicine" [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 967-973.
[3]	CAO Jie, TIAN Neng, WANG Huan. The Application of Cupping Therapy in Common Pediatric Diseases [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 902-906.
[4]	WANG Xiaolan, XIE Guifang, JIANG Yan, Zhang Xiaoqian, REN Kun. Study on Migration of Styrene from Disposable Intravenous Indwelling Needle in 5 Kinds of Liquid Medicine [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 954-959.
[5]	ZHU Xiaoyue, ZHANG Zhe, SUN Yi, AN Jingye, ZHENG Jie, WU Zhaowei. Improvement of Determination Method about Vitamin D₃ Assay in Standards for Calcium Carbonate and Vitamin D₃ Preparations [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 950-953.
[6]	KONG Weisong, CAO Dengyan, SHI Xuemin, XUE Ya, JIA Tingting, QIAN Fengdan, XU Yanfeng, ZHANG Lichao. Comparative Analysis of Requirements on Medical Institutions from Management Rules for Traditional Chinese Medicine Formula Granules among Provinces [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 960-966.
[7]	XIE Qing, GUO Qing, MIAO Lili. Relationship between the Risk of MACE during the Vulnerable Phase and Relevant Test Indexes in Patients with Acute Heart Failure [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 907-911.
[8]	LI Jihong, CHEN Jing, NIAN Honglei, WANG Xinghe. Exploration of the Full Chain Protection Strategy for the Rights and Interests of Participants in Clinical Research of Cell Therapy [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 987-994.
[9]	YIN Yanli, XU Renen. Application and Thinking of Remote Monitoring in Drug Regulation [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 878-881.
[10]	ZUO Yangbin, LI Jin, LIN Tianyu, WU Lijuan, CHEN Chunxi. Epidemiological Characteristics of Multi-Drug Resistant Mycobacterium Tuberculosis and Analysis of Factors Affecting Patient Treatment Adherence [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 982-986.
[11]	CHEN Wenping, WANG Guangping, ZHANG Ji. Hospital Pharmacovigilance System Based on Management Model of External Prescription Dispensing [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 882-888.
[12]	BIAN Xiaoyue, LIANG Yaxing, YIN Chen, YANG Xueying, WANG Hongying, ZHAO Yurong. Research Progress on 3D Printing Materials and 3D Printing Technology for Cranioplasty [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 889-895.
[13]	FU Jiyou, SHANG Qinghui, JIANG Lin, MAO Xiao, LI Yang. Research Progress on the Efficacy， Indications， Clinical Applications， and Modern Pharmacological Effects of Baibu [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 896-901.
[14]	LIU Chunyu, YANG Wanjun, WEI Namin, ZHANGnan , ZHAI Huaqiang, JIN Shiyuan. Bibliometrics Research on Traditional Chinese Medicine in the Treatment of Lung Cancer in Recent 10 Years [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 930-939.
[15]	LIU Zhihui, LU Meijing, YIN Li, YANG Yuanyuan, WANG Jiaxin, WANG Shigong. Study on the Characteristics and Meteorological Triggers of Circulatory System Diseases in Panzhihua Based on Machine Learning [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2025, 27(9): 974-981.

Analysis of Common Issues Regarding Changes in Registration Items of Special Cosmetics

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments